MD Research's  Instablog

MD Research
Send Message
I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach. I provide consulting to clients, both the retail and... More
My company:
Vincata Enterprises LLC
My blog:
Retail Investor 360
  • MannKind Corporation: A Simple But Intelligent Elucidation Of The Sanofi Partnership Deal 0 comments
    Aug 20, 2014 8:49 AM | about stocks: MNKD, SNY

    Published at Retail Investor 360: Monday, 18 August 2014 15:52Written by Doctor Hung V. Tran, MD, MS. Disclosure: We are long MNKD.

    Editorial Introduction. On August 11, 2014, MannKind disclosed the company had entered into a partnership agreement with the French global diabetes leader, Sanofi. Despite this positive development, the market has been highly negative on the news, perhaps due to confusions regarding the accounting/corporate terms of the deal. Many market participants just don't get it! MannKind now has command of vast armies of Sanofi sales and marketing reps to ultra rapidly deliver Afrezza to 28 million patients with diabetes in the U.S. alone.

    If you'd like to read more, please follow this LINK!

    Stocks: MNKD, SNY
Back To MD Research's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.